ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,166Medicare Part D Prescriptions Filled, Including Refills

Rank: 81 out of 387

$624K Total Retail Price of All Prescriptions

Rank: 89 out of 387

439 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 439 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

4% of this provider’s 8,453 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
CARVEDILOL 359 295 1 21
OMEPRAZOLE 357 298 2 4
FUROSEMIDE 354 284 3 7
METFORMIN HCL 318 206 4 8
LEVOTHYROXINE SODIUM 317 278 5 2
LOSARTAN POTASSIUM 312 273 6 24
LISINOPRIL 270 206 7 3
PRAVASTATIN SODIUM 263 207 8 15
HYDROCODONE-ACETAMINOPHEN 257 144 S3 9 1
TRIAMTERENE-HCTZ 249 224 10 55
AMLODIPINE BESYLATE 236 218 11 6
LOVASTATIN 233 185 12 36
CITALOPRAM HBR 215 153 13 19
MELOXICAM 185 121 14 22
POTASSIUM CHLORIDE 148 102 15 9
TRAMADOL HCL 147 100 16 14
SIMVASTATIN 146 120 17 5
ATENOLOL 144 118 18 20
GABAPENTIN 141 111 19 10
AMOX TR-POTASSIUM CLAVULANATE 139 96 20 131
METOPROLOL TARTRATE 138 108 21 11
GEMFIBROZIL 130 71 22 93
ZOLPIDEM TARTRATE 123 108 23 16
LEVOFLOXACIN 117 99 24 84
CYCLOBENZAPRINE HCL 106 65 R 25 42
RANITIDINE HCL 100 65 26 45
NEXIUM 93 57 27 26
HYDROCHLOROTHIAZIDE 88 55 28 12
NAMENDA 83 83 29 35
LOSARTAN-HYDROCHLOROTHIAZIDE 81 66 30 65
ALLOPURINOL 81 68 30 28
ADVAIR DISKUS 80 66 32 41
KLOR-CON M20 75 55 33 76
ALENDRONATE SODIUM 73 67 34 31
TERAZOSIN HCL 73 71 34 109
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 52 36 30
METOPROLOL SUCCINATE 71 60 37 18
ENALAPRIL MALEATE 71 58 37 69
ATORVASTATIN CALCIUM 70 48 39 13
MORPHINE SULFATE ER 70 54 S2 39 79
FENOFIBRATE 69 62 41 106
PROAIR HFA 65 45 42 47
SPIRIVA 64 53 43 61
WARFARIN SODIUM 64 60 43 17
GLYBURIDE 63 55 R 45 58
AMITRIPTYLINE HCL 63 39 R 45 62
TRAZODONE HCL 62 41 47 37
CLOPIDOGREL 61 38 48 25
SINGULAIR 60 41 49 83
CLONIDINE HCL 57 44 50 38
FLUTICASONE PROPIONATE 56 47 51 29
OXYBUTYNIN CHLORIDE ER 55 42 52 120
MEGESTROL ACETATE 52 51 R 53 123
GLIMEPIRIDE 52 50 53 50
MORPHINE SULFATE 51 39 S2 55 174
PANTOPRAZOLE SODIUM 50 37 56 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.